US is making COVID antiviral Paxlovid more available at test sites
The White House announced more steps to make the treatment more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.
The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the country as it projects COVID-19 infections will continue to spread over the summer travel season.
The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island. The site will provide patients with immediate access to the drug once they test positive.
More federally supported sites are set to open in the coming weeks in Massachusetts and New York City, both hit by a marked rise in infections. Next week, the U.S. will send authorized federal prescribers to several Minnesota-run testing sites, turning them into test-to-treat locations.